Form 4: Centessa Pharmaceuticals Executive Tia L. Bush Reports Share Disposal for Tax Obligations
SEC Form 4 Filing
Tia L. Bush, Chief Technology & Quality Officer of Centessa Pharmaceuticals, disposed of 6,419 ordinary shares to cover tax withholding obligations related to vesting restricted share units.
Summary
- On December 31, 2024, Tia L. Bush, the Chief Technology & Quality Officer of Centessa Pharmaceuticals plc, reported a transaction involving the disposal of 6,419 ordinary shares.
- The shares were disposed of to cover tax withholding obligations associated with the vesting of restricted share units.
- The transaction was executed at a price of $16.35 per share.
- Following the transaction, Bush directly owns 141,196 ordinary shares of Centessa Pharmaceuticals plc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine disposal of shares to cover tax obligations, which is a common practice.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares by an officer to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of the share disposal transaction and filing date of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.